New York State Common Retirement Fund’s Design Therapeutics DSGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$157K Buy
10,826
+8,800
+434% +$110K ﹤0.01% 2471
2026
Q1
$21.6K Hold
2,026
﹤0.01% 3003
2025
Q4
$19K Hold
2,026
﹤0.01% 3096
2025
Q3
$15.3K Hold
2,026
﹤0.01% 3137
2025
Q2
$6.83K Hold
2,026
﹤0.01% 3173
2025
Q1
$7.82K Hold
2,026
﹤0.01% 3098
2024
Q4
$12.5K Hold
2,026
﹤0.01% 3101
2024
Q3
$10.9K Hold
2,026
﹤0.01% 3100
2024
Q2
$6.79K Hold
2,026
﹤0.01% 3244
2024
Q1
$8.16K Hold
2,026
﹤0.01% 3199
2023
Q4
$5.37K Sell
2,026
-64
-3% -$147 ﹤0.01% 3215
2023
Q3
$4.93K Buy
2,090
+96
+5% +$448 ﹤0.01% 3237
2023
Q2
$12.6K Sell
1,994
-15,640
-89% -$95.7K ﹤0.01% 3257
2023
Q1
$102K Sell
17,634
-6,832
-28% -$51.1K ﹤0.01% 2812
2022
Q4
$251K Buy
24,466
+220
+0.9% +$2.98K ﹤0.01% 2630
2022
Q3
$405K Buy
24,246
+2,432
+11% +$48.4K ﹤0.01% 2443
2022
Q2
$305K Sell
21,814
-62
-0.3% -$837 ﹤0.01% 2593
2022
Q1
$353K Buy
21,876
+8,919
+69% +$137K ﹤0.01% 2561
2021
Q4
$277K Buy
12,957
+1,219
+10% +$20.9K ﹤0.01% 2747
2021
Q3
$172K Buy
11,738
+138
+1% +$2.29K ﹤0.01% 2969
2021
Q2
$231K Buy
+11,600
New +$293K ﹤0.01% 2988

Other funds holding DSGN

New York State Common Retirement Fund's DSGN Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Design Therapeutics (DSGN) stake by 434% in Q2 2026, buying an estimated $110K and bringing the position to 10,826 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #2471.

New York State Common Retirement Fund first reported a position in DSGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $405K in Q3 2022. 23 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • New York State Common Retirement Fund held 10,826 shares of Design Therapeutics worth $157K as of Q2 2026.
  • New York State Common Retirement Fund bought 8,800 Design Therapeutics shares in Q2 2026, an estimated $110K.
  • Design Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2471 holding.
  • New York State Common Retirement Fund first reported a position in Design Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • New York State Common Retirement Fund's Design Therapeutics position peaked at $405K in Q3 2022.
  • 23 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.